Gainers
- Protagenic Therapeutics PTIX shares rose 85.8% to $0.42 during Thursday's regular session. The market value of their outstanding shares is at $3.0 million. As per the news, the Q4 earnings report came out 3 days ago.
- OSR Holdings OSRH shares moved upwards by 59.18% to $2.34. The market value of their outstanding shares is at $45.1 million.
- Aptevo Therapeutics APVO shares rose 45.67% to $2.01. The company's market cap stands at $2.9 million.
- Alaunos Therapeutics TCRT shares rose 38.75% to $3.88. The market value of their outstanding shares is at $6.2 million.
- Genprex GNPX shares moved upwards by 31.33% to $0.39. The market value of their outstanding shares is at $3.2 million.
- Tivic Health Systems TIVC shares increased by 30.76% to $4.25. The company's market cap stands at $2.6 million.
Losers
- Aldeyra Therapeutics ALDX stock declined by 73.7% to $1.4 during Thursday's regular session. The company's market cap stands at $83.3 million.
- Virpax Pharmaceuticals VRPX shares decreased by 61.61% to $0.47.
- RxSight RXST stock fell 39.29% to $15.86. The market value of their outstanding shares is at $642.1 million.
- Impact BioMedical IBO stock decreased by 18.3% to $0.47. The market value of their outstanding shares is at $5.3 million.
- CervoMed CRVO shares decreased by 17.75% to $11.17. The market value of their outstanding shares is at $97.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ALDXAldeyra Therapeutics Inc
$2.06-1.86%
Edge Rankings
Momentum
7.80
Price Trend
Short
Medium
Long
APVOAptevo Therapeutics Inc
$0.3986-2.78%
CRVOCervoMed Inc
$8.91-5.01%
GNPXGenprex Inc
$0.2712-7.25%
IBOImpact BioMedical Inc
$0.5299-13.1%
OSRHOSR Holdings Inc
$1.32-%
PTIXProtagenic Therapeutics Inc
$3.403.81%
RXSTRxSight Inc
$14.906.81%
TCRTAlaunos Therapeutics Inc
$2.82-2.76%
TIVCTivic Health Systems Inc
$4.400.85%
VRPXVirpax Pharmaceuticals Inc
$0.2400-19.9%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in